Skip to main content
Clinical Trials/ACTRN12608000389303
ACTRN12608000389303
Recruiting
Phase 3

Efficacy of blood glucose self-monitoring and intensive education in patients with type 2 diabetes not receiving insulin: a pilot study

Consorzio Mario Negri Sud0 sites80 target enrollmentAugust 4, 2008

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
non insulin dependent diabetes
Sponsor
Consorzio Mario Negri Sud
Enrollment
80
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 4, 2008
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Consorzio Mario Negri Sud

Eligibility Criteria

Inclusion Criteria

  • Patients with Type 2 diabetes (known diabetes or new diagnosis) seen for the first time in the diabetes outpatient clinic;
  • Patients on treatment with oral hypoglycaemic agents (OHA) monotherapy (i.e. metformin alone or sulphonyloureas alone or thiazolidinediones (TZDs) alone);
  • No need for insulin treatment;
  • Male and female patients, aged between 45\-75 years;
  • Hba1c values between 7% and 9% included (considering a value of 6\.0% as the upper limit of normal value)
  • No experience of self monitoring of blood glucose (SMBG) in the previous 12 months (SMBG performed with a frequency of \< 1 times/week)
  • Ability and willingness to comply with all study requirements
  • Signature of consent form

Exclusion Criteria

  • insulin therapy or more than one oral hypoglycaemic agents (OHA);
  • need of self monitoring of blood glucose (SMBG);
  • concomitant serious illnesses causing a reduction of life expectancy;
  • physical or mental problems preventing the self monitoring of blood glucose (SMBG);
  • patient management shared with general practitioner (GP).

Outcomes

Primary Outcomes

Not specified

Similar Trials